MedTrace Logo

Clinical Study of Approved and Investigational Contact Lenses

NCT02708524 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 554

Last updated 2016-11-09

Study results available
· View outcomes & findings →

Summary

This is a multi-site, 5-visit, double-masked, dispensing study comparing an investigational contact lens with currently-marketed contact lenses. The objective of the study is to evaluate the comfort of the lenses when worn for 30 (-2/+6) days on daily wear modality.

Conditions

  • Visual Acuity

Interventions

DEVICE

Senofilcon C Contact Lens

DEVICE

Comfilcon A Contact Lens

DEVICE

Lotrafilcon B Contact Lens

DEVICE

Samfilcon A Contact Lens

Sponsors & Collaborators

  • Johnson & Johnson Vision Care, Inc.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2016-03-31
Completion
2016-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02708524 on ClinicalTrials.gov